Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Kyle Rove

Concepts (286)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urologic Surgical Procedures
11
2024
107
3.620
 Why?
Prostatic Neoplasms
17
2014
998
2.990
 Why?
Androgen Antagonists
5
2014
79
1.940
 Why?
Perioperative Care
3
2024
151
1.870
 Why?
Urology
5
2024
56
1.780
 Why?
Analgesics, Opioid
8
2024
913
1.750
 Why?
Pain, Postoperative
5
2024
235
1.740
 Why?
Urinary Bladder, Neurogenic
3
2024
35
1.550
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2024
338
1.360
 Why?
Urinary Bladder
4
2022
175
1.280
 Why?
Postoperative Complications
9
2024
2477
1.270
 Why?
Urodynamics
3
2024
35
1.140
 Why?
Testosterone
5
2015
372
1.100
 Why?
Urinary Bladder Neoplasms
3
2017
226
0.940
 Why?
Abdominal Neoplasms
1
2024
34
0.920
 Why?
Testicular Neoplasms
2
2016
102
0.920
 Why?
Practice Patterns, Physicians'
3
2024
1271
0.900
 Why?
Specialties, Surgical
1
2025
74
0.870
 Why?
Physicians, Women
1
2025
71
0.870
 Why?
Neoplasms, Hormone-Dependent
2
2014
38
0.850
 Why?
Surgeons
2
2025
264
0.840
 Why?
Propensity Score
1
2024
264
0.810
 Why?
Child
27
2024
20884
0.810
 Why?
Delphi Technique
1
2024
225
0.810
 Why?
Urinary Bladder Diseases
1
2022
18
0.800
 Why?
Drug Prescriptions
1
2024
248
0.800
 Why?
Pediatrics
3
2024
1056
0.780
 Why?
Ureter
1
2022
35
0.770
 Why?
Gonadotropin-Releasing Hormone
3
2014
205
0.760
 Why?
Consensus
2
2024
618
0.750
 Why?
Postoperative Nausea and Vomiting
1
2020
11
0.710
 Why?
Urologic Diseases
2
2018
38
0.710
 Why?
Length of Stay
8
2024
1122
0.700
 Why?
Spinal Dysraphism
2
2022
68
0.680
 Why?
Analgesia
1
2020
100
0.640
 Why?
Renal Insufficiency, Chronic
1
2024
566
0.610
 Why?
Humans
58
2025
129625
0.600
 Why?
Wolfram Syndrome
1
2018
4
0.600
 Why?
Pons
1
2018
26
0.590
 Why?
Bone Neoplasms
2
2011
229
0.590
 Why?
Electronic Health Records
2
2025
973
0.580
 Why?
Urination
1
2018
44
0.580
 Why?
Male
36
2025
63670
0.570
 Why?
Prostate-Specific Antigen
4
2014
160
0.570
 Why?
Lower Urinary Tract Symptoms
1
2018
54
0.550
 Why?
Prospective Studies
11
2024
7135
0.540
 Why?
Recovery of Function
2
2018
642
0.540
 Why?
Sertoli-Leydig Cell Tumor
1
2016
8
0.530
 Why?
Bariatric Surgery
1
2020
196
0.530
 Why?
Acute Kidney Injury
1
2024
791
0.520
 Why?
Cystoscopy
1
2016
19
0.520
 Why?
Evidence-Based Medicine
2
2018
712
0.510
 Why?
Sex Cord-Gonadal Stromal Tumors
1
2015
5
0.500
 Why?
Child, Preschool
10
2024
10490
0.500
 Why?
Cause of Death
2
2023
395
0.490
 Why?
Prostate
2
2012
173
0.440
 Why?
Patient Care Team
2
2018
600
0.430
 Why?
Hyperoxaluria, Primary
2
2023
14
0.410
 Why?
Kidney Calculi
2
2023
35
0.410
 Why?
Pediatric Obesity
1
2020
573
0.400
 Why?
Incidence
4
2024
2641
0.400
 Why?
Tonsillectomy
2
2024
82
0.400
 Why?
Antineoplastic Agents, Hormonal
1
2013
155
0.380
 Why?
Referral and Consultation
1
2017
730
0.380
 Why?
Retrospective Studies
13
2025
14522
0.380
 Why?
Adolescent
12
2024
20412
0.360
 Why?
Azasteroids
1
2011
4
0.360
 Why?
5-alpha Reductase Inhibitors
1
2011
14
0.360
 Why?
Orchiectomy
3
2016
67
0.350
 Why?
Disease Progression
4
2015
2627
0.350
 Why?
Kidney Neoplasms
3
2019
348
0.340
 Why?
Anticarcinogenic Agents
1
2011
77
0.340
 Why?
Registries
1
2018
1899
0.330
 Why?
Sleep Apnea, Obstructive
2
2024
275
0.320
 Why?
Risk Assessment
4
2024
3262
0.310
 Why?
Neoplasm Staging
4
2016
1282
0.300
 Why?
Early Detection of Cancer
2
2011
370
0.290
 Why?
Wilms Tumor
2
2019
78
0.290
 Why?
Female
15
2025
68734
0.280
 Why?
Adenoidectomy
2
2024
65
0.270
 Why?
Sex Factors
2
2025
1970
0.250
 Why?
Antineoplastic Agents
3
2012
2046
0.250
 Why?
Case-Control Studies
3
2023
3378
0.240
 Why?
Fractures, Bone
1
2009
394
0.220
 Why?
Prognosis
3
2018
3774
0.220
 Why?
Nephrocalcinosis
1
2023
3
0.220
 Why?
Nephrolithiasis
1
2023
10
0.220
 Why?
Young Adult
6
2024
12455
0.220
 Why?
Neoplasm Metastasis
2
2016
611
0.210
 Why?
Ureteral Calculi
1
2023
13
0.210
 Why?
Lithotripsy
1
2023
43
0.200
 Why?
Analgesia, Epidural
1
2022
23
0.200
 Why?
Meningomyelocele
1
2023
55
0.190
 Why?
Survival Analysis
2
2016
1269
0.190
 Why?
Hydrocephalus
1
2023
103
0.190
 Why?
Stents
2
2023
504
0.180
 Why?
Device Removal
1
2022
136
0.180
 Why?
Cohort Studies
2
2024
5426
0.180
 Why?
Diphosphonates
2
2011
58
0.170
 Why?
RANK Ligand
2
2010
26
0.170
 Why?
Treatment Outcome
6
2023
10219
0.170
 Why?
Radiotherapy
2
2012
185
0.170
 Why?
Anastomosis, Surgical
1
2020
149
0.170
 Why?
Age Factors
2
2018
3152
0.160
 Why?
Caregivers
2
2024
806
0.160
 Why?
Combined Modality Therapy
2
2014
1203
0.160
 Why?
Sex-Determining Region Y Protein
1
2019
2
0.160
 Why?
WT1 Proteins
1
2019
14
0.160
 Why?
Emotions
1
2024
545
0.160
 Why?
Nephrotic Syndrome
1
2019
28
0.150
 Why?
Disorders of Sex Development
1
2019
38
0.150
 Why?
Magnetic Resonance Imaging
3
2019
3394
0.150
 Why?
Urethral Neoplasms
1
2018
1
0.150
 Why?
Follow-Up Studies
3
2018
4894
0.150
 Why?
Hypertension, Renal
1
2018
16
0.150
 Why?
Paraganglioma, Extra-Adrenal
1
2018
7
0.150
 Why?
Urethral Obstruction
1
2018
9
0.150
 Why?
Polyps
1
2018
11
0.150
 Why?
Renal Artery Obstruction
1
2018
29
0.150
 Why?
Surveys and Questionnaires
4
2024
5415
0.140
 Why?
Kidney Failure, Chronic
1
2023
546
0.140
 Why?
Urethra
1
2018
52
0.140
 Why?
Prenatal Diagnosis
1
2019
194
0.140
 Why?
Practice Guidelines as Topic
2
2018
1501
0.140
 Why?
Adult
8
2024
35599
0.140
 Why?
Pain Management
1
2020
324
0.140
 Why?
Intestines
1
2020
347
0.140
 Why?
Organ Size
1
2018
446
0.140
 Why?
Men's Health
1
2017
7
0.140
 Why?
Decision Making
1
2024
863
0.140
 Why?
Infant
2
2024
8995
0.130
 Why?
Postoperative Period
1
2018
330
0.130
 Why?
Immunotherapy
2
2011
596
0.130
 Why?
Review Literature as Topic
1
2017
66
0.130
 Why?
Tertiary Care Centers
1
2017
148
0.130
 Why?
Databases, Factual
2
2022
1269
0.130
 Why?
Feminization
1
2015
6
0.130
 Why?
Mitotic Index
1
2015
26
0.120
 Why?
Intermittent Urethral Catheterization
1
2015
3
0.120
 Why?
Urination Disorders
1
2015
13
0.120
 Why?
Ultrasonography
3
2019
712
0.120
 Why?
Colorectal Neoplasms
1
2022
749
0.120
 Why?
Cloaca
1
2015
48
0.120
 Why?
Neoplasm Invasiveness
1
2016
481
0.120
 Why?
Disease-Free Survival
1
2016
646
0.120
 Why?
Patient Reported Outcome Measures
1
2018
374
0.110
 Why?
Antibodies, Monoclonal
2
2011
1366
0.110
 Why?
Kaplan-Meier Estimate
1
2016
851
0.110
 Why?
Risk Factors
3
2018
9786
0.110
 Why?
Self Report
1
2018
799
0.110
 Why?
Image Processing, Computer-Assisted
1
2018
740
0.110
 Why?
Infant, Newborn
4
2019
5756
0.100
 Why?
Creatinine
1
2015
490
0.100
 Why?
Estrogens
1
2015
347
0.100
 Why?
Quality of Life
2
2018
2688
0.100
 Why?
Telemedicine
1
2021
792
0.100
 Why?
Radiation-Protective Agents
1
2012
26
0.100
 Why?
Multivariate Analysis
1
2016
1499
0.100
 Why?
Drug Design
1
2013
158
0.100
 Why?
Alpha Particles
1
2011
1
0.100
 Why?
Beta Particles
1
2011
1
0.100
 Why?
Metalloporphyrins
1
2012
101
0.100
 Why?
Endothelin A Receptor Antagonists
1
2011
24
0.100
 Why?
Clusterin
1
2011
11
0.100
 Why?
Receptors, Androgen
1
2013
143
0.090
 Why?
Blood Chemical Analysis
1
2012
97
0.090
 Why?
Mitomycin
1
2011
32
0.090
 Why?
Drug Costs
1
2012
100
0.090
 Why?
Kidney
2
2019
1386
0.090
 Why?
Valproic Acid
1
2011
47
0.090
 Why?
Dutasteride
1
2011
4
0.090
 Why?
Carcinoma, Transitional Cell
1
2011
59
0.090
 Why?
Logistic Models
1
2016
1986
0.090
 Why?
Bone Density Conservation Agents
1
2011
70
0.090
 Why?
Androstenols
1
2010
4
0.090
 Why?
Denosumab
1
2010
8
0.090
 Why?
Tissue Extracts
1
2010
19
0.090
 Why?
Imaging, Three-Dimensional
2
2012
528
0.090
 Why?
Antibiotics, Antineoplastic
1
2011
123
0.090
 Why?
Prostatic Hyperplasia
1
2011
41
0.090
 Why?
Guideline Adherence
1
2015
527
0.090
 Why?
Androstenes
1
2010
17
0.090
 Why?
Dihydrotestosterone
1
2011
41
0.090
 Why?
Longitudinal Studies
1
2018
2720
0.090
 Why?
Patient Care Management
1
2011
56
0.090
 Why?
Biomedical Research
1
2017
640
0.090
 Why?
Phenylthiohydantoin
1
2010
41
0.090
 Why?
Taxoids
1
2010
98
0.090
 Why?
Ultrasound, High-Intensity Focused, Transrectal
1
2010
2
0.080
 Why?
Antigens, Neoplasm
1
2012
308
0.080
 Why?
Benzamides
1
2010
203
0.080
 Why?
Hormone Antagonists
1
2009
33
0.080
 Why?
Nitriles
1
2010
170
0.080
 Why?
Cost-Benefit Analysis
1
2012
569
0.080
 Why?
Histone Deacetylase Inhibitors
1
2011
209
0.080
 Why?
Mobility Limitation
1
2009
61
0.080
 Why?
Bone Remodeling
1
2009
71
0.080
 Why?
Collagen Type I
1
2009
118
0.080
 Why?
Risk
1
2011
855
0.080
 Why?
Antioxidants
1
2012
558
0.080
 Why?
Middle Aged
6
2016
31136
0.080
 Why?
Aged
4
2016
22061
0.080
 Why?
Continuity of Patient Care
1
2011
273
0.080
 Why?
Drug Resistance, Neoplasm
1
2013
752
0.070
 Why?
Mutation
1
2019
3717
0.070
 Why?
Biomarkers, Tumor
1
2014
1164
0.070
 Why?
Computer Simulation
1
2011
939
0.070
 Why?
Software
1
2011
608
0.060
 Why?
Randomized Controlled Trials as Topic
1
2011
1365
0.060
 Why?
Protein Kinase Inhibitors
1
2011
887
0.060
 Why?
Antibodies, Monoclonal, Humanized
1
2010
757
0.060
 Why?
Peptides
1
2009
926
0.060
 Why?
Calcium Oxalate
1
2023
5
0.050
 Why?
Ambulatory Surgical Procedures
1
2024
58
0.050
 Why?
Mass Screening
1
2011
1190
0.050
 Why?
Ureteroscopy
1
2023
16
0.050
 Why?
Polysomnography
1
2024
174
0.050
 Why?
Predictive Value of Tests
2
2022
1947
0.050
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2011
1560
0.050
 Why?
Ventriculoperitoneal Shunt
1
2023
34
0.050
 Why?
Colostomy
1
2022
26
0.050
 Why?
Animals
3
2013
35391
0.050
 Why?
Morphine
1
2022
138
0.050
 Why?
Multicenter Studies as Topic
1
2022
286
0.050
 Why?
Internship and Residency
1
2011
1050
0.050
 Why?
Urologists
1
2021
17
0.040
 Why?
United States
1
2017
13871
0.040
 Why?
Feasibility Studies
1
2023
869
0.040
 Why?
Signal Transduction
1
2013
4931
0.040
 Why?
Oxygen
1
2023
915
0.040
 Why?
Cytoskeletal Proteins
1
2019
148
0.040
 Why?
Patient Readmission
1
2024
653
0.040
 Why?
Pilot Projects
1
2023
1592
0.040
 Why?
Normetanephrine
1
2018
2
0.040
 Why?
Metanephrine
1
2018
2
0.040
 Why?
Cystography
1
2018
1
0.040
 Why?
Renin
1
2018
32
0.040
 Why?
Lymph Node Excision
1
2019
164
0.040
 Why?
Urinary Retention
1
2018
20
0.040
 Why?
Nephrectomy
1
2019
158
0.040
 Why?
Chemotherapy, Adjuvant
1
2019
377
0.040
 Why?
DNA Mutational Analysis
1
2019
382
0.040
 Why?
Abnormalities, Multiple
1
2019
179
0.030
 Why?
Norepinephrine
1
2018
210
0.030
 Why?
Patient Satisfaction
1
2021
633
0.030
 Why?
Computed Tomography Angiography
1
2018
115
0.030
 Why?
Epithelium
1
2018
314
0.030
 Why?
Global Burden of Disease
1
2017
18
0.030
 Why?
Urologic Neoplasms
1
2017
26
0.030
 Why?
Infertility, Male
1
2017
61
0.030
 Why?
Quality-Adjusted Life Years
1
2017
106
0.030
 Why?
Adaptor Proteins, Signal Transducing
1
2019
399
0.030
 Why?
Genetic Testing
1
2019
430
0.030
 Why?
Statistics, Nonparametric
1
2017
419
0.030
 Why?
Endoscopy
1
2018
288
0.030
 Why?
Urinary Diversion
1
2015
12
0.030
 Why?
Kidney Function Tests
1
2015
152
0.030
 Why?
Diagnosis, Differential
1
2019
1432
0.030
 Why?
Pandemics
1
2021
1491
0.030
 Why?
Image-Guided Biopsy
1
2012
37
0.030
 Why?
Penis
1
2012
35
0.020
 Why?
Erectile Dysfunction
1
2012
39
0.020
 Why?
Radiation, Ionizing
1
2012
76
0.020
 Why?
Prostatectomy
1
2012
103
0.020
 Why?
Testis
1
2012
145
0.020
 Why?
Emergency Service, Hospital
1
2023
1914
0.020
 Why?
Neoplasm Grading
1
2012
282
0.020
 Why?
Glomerular Filtration Rate
1
2015
712
0.020
 Why?
Cross-Sectional Studies
1
2022
5075
0.020
 Why?
Biopsy, Needle
1
2011
188
0.020
 Why?
Drug Synergism
1
2011
370
0.020
 Why?
Efficiency
1
2011
91
0.020
 Why?
DNA Damage
1
2012
384
0.020
 Why?
Tumor Cells, Cultured
1
2011
943
0.020
 Why?
Reference Values
1
2011
794
0.020
 Why?
Workload
1
2011
153
0.020
 Why?
Tomography, X-Ray Computed
1
2019
2512
0.020
 Why?
Safety
1
2011
335
0.020
 Why?
Drug Therapy, Combination
1
2011
1042
0.020
 Why?
Skin
1
2012
727
0.020
 Why?
Rats, Sprague-Dawley
1
2012
2395
0.020
 Why?
Pregnancy
1
2019
6417
0.020
 Why?
Time Factors
1
2017
6555
0.020
 Why?
Models, Biological
1
2012
1724
0.010
 Why?
Rats
1
2012
5483
0.010
 Why?
Reproducibility of Results
1
2011
3080
0.010
 Why?
Rove's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (286) concept(s)
_
Co-Authors Expand Description
See all (36) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)